Hik­ma to pay $115M in cash, $35M in do­na­tions to set­tle opi­oid claims

Lon­don-based Hik­ma Phar­ma­ceu­ti­cals has reached an agree­ment to set­tle al­le­ga­tions brought against the com­pa­ny by US states and lo­cal gov­ern­ments for the man­u­fac­tur­ing and sale of opi­oids.

Un­der the agree­ment, Hik­ma will pay up to $115 mil­lion in cash and $35 mil­lion in do­na­tions of Hik­ma’s nalox­one, which re­vers­es the ef­fects of an over­dose. But the deal still de­pends on the num­ber of states and lo­cal gov­ern­ments that de­cide to opt in to Hik­ma’s propo­si­tion. The com­pa­ny added that the agree­ment isn’t an ad­mis­sion of wrong­do­ing and will con­tin­ue to fight in court any law­suits the deal doesn’t re­solve.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER